acut
lower
respiratori
infect
alri
major
caus
hospit
indigen
children
remot
region
australia
associ
microbiolog
remain
unclear
aim
determin
whether
microb
present
nasopharynx
alri
associ
onset
retrospect
casecontrolcrossov
studi
among
indigen
children
age
year
alri
case
identifi
medic
note
review
elig
nasopharyng
swab
avail
day
alri
onset
case
day
alri
onset
child
control
time
agematch
children
without
alri
differ
child
control
pcr
assay
determin
presenc
andor
load
select
respiratori
pathogen
among
children
record
alri
episod
casesam
child
control
casediffer
child
control
swab
pair
identifi
human
adenovirus
hadv
preval
case
compar
child
control
vs
ci
p
associ
signific
case
versu
differ
child
control
vs
ci
p
microb
preval
case
compar
control
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
commonli
identifi
heidi
c
smithvaughan
michael
j
bink
contribut
equal
work
onlin
version
articl
http
contain
supplementari
materi
avail
author
user
across
swab
pediatr
popul
high
detect
rate
nasopharyng
microb
hadv
pathogen
detect
period
ill
present
significantli
associ
alri
onset
detect
potenti
alri
pathogen
similar
case
control
acut
lower
respiratori
infect
alri
major
caus
clinic
present
hospit
young
indigen
children
live
remot
region
australia
onefifth
indigen
infant
born
australia
northern
territori
nt
hospit
alri
first
year
life
report
incid
radiolog
confirm
pneumonia
per
childyear
among
nt
children
age
year
bronchiol
per
childyear
age
month
moreov
pneumococc
conjug
vaccin
introduc
significantli
reduc
incid
radiolog
confirm
pneumonia
among
children
age
month
despit
import
alri
set
microbiolog
associ
remain
poorli
character
two
publish
studi
date
hospitalbas
worldwid
mani
studi
identifi
presenc
virus
bacteria
children
respiratori
secret
alri
howev
contribut
infect
individu
microb
polymicrobi
commun
microbehost
interact
individu
popul
level
remain
poorli
understood
furthermor
valu
nasopharyng
swab
np
inform
microbiolog
lung
question
exampl
nt
children
hospit
pneumonia
nasopharyng
bacteria
virus
associ
clinic
sign
admiss
recoveri
question
util
np
taken
time
alri
clinic
diagnosi
prognosi
children
alreadi
high
carriag
respiratori
pathogen
recent
data
perch
studi
confirm
limit
valu
crosssect
np
diagnos
alri
microaspir
secret
upper
airway
like
precursor
alri
nasopharyng
secret
abund
bacterialaden
secret
like
aspir
particularli
young
children
immatur
laryng
chemoreflex
indigen
children
remot
nt
commun
arguabl
high
risk
microaspir
respiratori
bacteria
eg
streptococcu
pneumonia
haemophilu
influenza
virus
microb
detect
np
taken
asymptomat
infant
young
children
enrol
communitybas
studi
therefor
set
examin
nasopharyng
microb
rather
alri
may
provid
import
inform
initi
pathogenesi
infect
alri
remain
complex
problem
made
challeng
lack
method
determin
etiolog
comprom
prevent
treatment
strategi
given
limit
avail
data
etiolog
communitybas
alri
difficulti
sampl
lung
aim
investig
whether
prior
presenc
load
specif
bacteria
virus
nasopharynx
associ
develop
alri
episod
cohort
young
indigen
children
live
nt
hypothes
preval
respiratori
bacteri
viral
pathogen
np
specimen
would
higher
alri
episod
control
retrospect
nest
casecontrol
casecrossov
analysi
fig
clinic
data
sampl
collect
indigen
children
age
day
year
enrol
previous
two
complet
studi
undertaken
tabl
aim
achiev
match
case
control
ratio
allow
control
avail
np
store
skimmilk
trypton
glucos
glycerol
broth
research
nurs
identifi
alri
case
review
health
centr
hospit
medic
record
hospit
alri
episod
defin
fever
least
one
follow
within
h
present
abnorm
chest
radiograph
show
pulmonari
infiltr
ageadjust
respiratori
rate
threshold
breathsmin
month
breathsmin
year
crackl
wheez
bronchial
breath
auscult
commun
alri
episod
defin
fever
chest
wall
recess
tachypnea
withwithout
crackl
wheez
pneumonia
bronchiol
diagnos
record
health
centr
note
medic
admiss
select
np
fig
np
sampl
strategi
np
collect
particip
everi
week
first
month
life
age
year
tabl
case
np
collect
day
alri
episod
limit
potenti
age
bia
np
select
infant
age
day
scc
np
chosen
day
alri
episod
casecrossov
analys
children
age
day
case
np
collect
scc
np
chosen
day
alri
avoid
select
np
collect
child
day
age
dcc
np
select
within
day
case
np
children
within
day
age
match
age
season
casecontrol
analysi
dcc
np
exclud
collect
within
day
alri
episod
control
child
origin
studi
otiti
media
identifi
video
otoscopi
clinic
record
use
identifi
recent
antibiot
prescript
within
day
np
vaccin
statu
defin
dose
administ
least
week
prior
time
np
collect
bacteri
viral
test
store
np
stggb
previous
perform
success
viral
pcr
detect
type
specimen
batchtest
respiratori
syncyti
viru
rsva
b
human
rhinoviru
hrv
influenza
viru
ifva
b
parainfluenza
viru
human
metapneumoviru
hmpv
human
coronaviru
human
enteroviru
hev
human
adenoviru
hadv
human
human
polyomavirus
hpyvwu
ki
use
previous
valid
realtim
pcr
assay
hadv
hrv
type
perform
describ
bacteri
pcr
detect
quantif
pneumonia
h
influenza
moraxella
catarrhali
staphylococcu
aureu
detect
quantifi
pcr
follow
publish
method
chlamydophila
pneumonia
mycoplasma
pneumonia
detect
pcr
describ
summari
statist
present
median
rang
continu
variabl
frequenc
categor
variabl
condit
logist
regress
use
comparison
characterist
pathogen
presenceabs
log
transform
respiratori
bacteri
load
case
control
condit
logist
regress
model
assess
influenc
antibiot
statu
otiti
media
sampl
independ
one
anoth
eg
wherea
child
could
suppli
case
scc
swab
could
also
suppli
dcc
anoth
child
use
singl
swab
match
ratio
allow
analysi
perform
use
stata
version
p
valu
consid
statist
signific
data
avail
dataset
gener
andor
analys
current
studi
avail
correspond
author
reason
request
elig
children
identifi
alri
episod
children
fig
total
alri
case
episod
children
abl
match
control
either
child
casescc
differ
child
casedcc
children
contribut
one
two
alri
case
among
alri
episod
specifi
bronchiol
case
specifi
pneumonia
xray
confirm
case
remaind
met
inclus
criteria
alri
could
categor
casecrossov
analysi
match
case
children
elig
scc
children
casescc
group
total
casecontrol
analysi
match
case
children
elig
dcc
n
children
casedcc
group
total
casescc
casedcc
group
match
otherwis
control
use
altern
control
avail
child
comparison
median
time
case
np
alri
episod
day
rang
scc
pair
case
np
day
rang
differ
child
comparison
median
time
case
np
alri
episod
day
rang
dcc
pair
case
np
day
rang
children
clinic
characterist
tabl
show
high
preval
concurr
ear
diseas
male
gender
imbal
match
case
dcc
p
receipt
two
dose
schedul
month
age
least
frequent
scc
np
due
select
strategi
scc
np
chosen
earlier
case
np
recent
antibiot
use
within
day
np
commonli
preced
control
np
scc
dcc
compar
respect
case
np
scc
p
dcc
p
unadjust
condit
logist
regress
analys
tabl
fig
fig
similarli
presenc
virus
test
associ
subsequ
alri
scc
dcc
analys
condit
logist
regress
analysi
adjust
recent
antibiot
use
casescc
analysi
gender
antibiot
use
casedcc
analysi
influenc
interpret
unadjust
analysi
preval
hcov
rsv
ifv
piv
hadv
hrv
subtyp
present
per
casecontrol
group
onlin
resourc
tabl
small
number
individu
genotyp
preclud
analysi
associ
alri
neither
bacteri
presenc
densiti
associ
subsequ
alri
bacteri
load
data
pneumonia
h
influenza
catarrhali
identifi
similar
distribut
compar
case
control
condit
logist
regress
analysi
compar
microb
codetect
case
control
overal
preval
magnitud
signific
casescc
associ
hadv
tabl
tabl
case
versu
dcc
comparison
shown
analysi
pool
data
across
np
specimen
found
signific
posit
associ
codetect
h
influenza
hrv
p
even
adjust
codetect
recent
antibiot
age
howev
h
influenzaehrv
codetect
tabl
associ
alri
case
catarrhali
associ
alri
onset
carriag
preval
pathogen
high
case
control
potenti
complic
analys
associ
due
satur
hadv
microbi
signal
associ
alri
onset
odd
nasopharyng
hadv
detect
higher
period
immedi
alri
episod
compar
earlier
alrifre
period
child
p
hadv
identifi
pathogen
interest
previou
studi
popul
found
hadv
detect
np
specimen
independ
associ
sever
otiti
media
larg
childhood
pneumonia
aetiolog
studi
south
africa
high
incid
pneumonia
report
rsv
np
swab
strongli
associ
pneumonia
casecontrol
comparison
follow
ifv
hbov
hadv
cytomegaloviru
addit
analysi
induc
sputum
specimen
also
identifi
bordetella
pertussi
h
influenza
type
b
pneumonia
piv
associ
pneumonia
whilst
metaanalysi
studi
demonstr
rsv
ifv
piv
hmpv
hrv
tabl
viral
bacteri
load
data
unabl
assess
one
differ
case
nasopharyng
swab
odd
ratio
shown
fig
nasopharyng
swab
could
test
c
pneumonia
pneumonia
scc
comparison
control
dcc
comparison
control
adjust
recent
antibiot
use
presenc
otiti
media
pneumococc
conjug
vaccin
alter
interpret
cell
contain
outcom
p
valu
gener
use
exact
logist
regress
model
ital
indic
statist
signific
differ
associ
alri
children
age
year
signific
differ
detect
hadv
case
control
recent
prospect
communitybas
longitudin
birth
cohort
studi
involv
nonindigen
australian
children
also
could
attribut
parentreport
alri
symptom
detect
hadv
pcr
weekli
collect
nasal
swab
specimen
nonetheless
hadv
diseas
outbreak
known
occur
exampl
type
observ
children
taiwan
commun
outbreak
type
associ
sever
diseas
hadv
outbreak
also
occur
militari
train
centr
associ
crowd
live
condit
howev
reintroduct
type
vaccin
follow
reduct
acut
respiratori
infect
popul
whilst
hadv
type
hadv
b
detect
studi
hadv
c
type
common
shown
previous
respiratori
specimen
anoth
australian
studi
presenc
microb
may
contribut
alri
develop
may
primari
sole
caus
respiratori
virus
promot
bacteri
superinfect
multipl
mechan
decreas
bacteri
clearanc
increas
bacteri
adher
suppress
immun
recoveri
review
bacteria
also
promot
viral
infect
facilit
attach
host
cell
contribut
elev
viru
product
releas
airway
cell
review
howev
metaanalysi
studi
found
evid
support
role
viral
coinfect
increas
diseas
sever
inconclus
studi
signific
pathogen
associ
identifi
h
influenza
hrv
studi
strength
casecrossov
analysi
design
account
proxim
risk
factor
host
eg
genet
environment
factor
eg
smoke
exposur
could
influenc
suscept
alri
nevertheless
perform
secondari
analysi
specimen
data
studi
specif
design
address
aim
furthermor
diagnost
classif
reli
clinic
record
may
lack
accuraci
addit
alri
episod
rang
mild
sever
diseas
underrepresent
hospit
case
clinic
heterogen
may
translat
microbi
differ
thu
futur
studi
analys
rang
diseas
phenotyp
inde
previous
found
np
indigen
infant
hospit
bronchiol
rsvposit
np
rsvposit
case
current
studi
despit
bronchiol
common
diagnosi
episod
differ
may
due
sampl
primarili
nonhospit
alri
case
infant
outsid
first
month
life
limit
alri
studi
base
np
microbiolog
relat
infer
causat
infect
distal
area
respiratori
tract
wherea
studi
investig
microbi
exposur
concurr
outcom
studi
captur
nasopharyng
microbiolog
prior
alri
onset
account
possibl
origin
infect
organ
clear
possibl
pathogen
detect
case
np
may
clear
alri
episod
acquir
subsequ
np
collect
howev
subanalysi
case
np
collect
within
day
alri
episod
identifi
hadv
trend
consist
main
analysi
investig
highrisk
popul
alri
affect
experienc
multipl
alri
episod
first
year
life
make
us
question
suitabl
control
cohort
whilst
attempt
prevent
misclassif
bia
use
strict
criteria
control
np
specimen
high
background
rate
pathogenposit
np
design
element
allow
case
control
np
sought
set
children
may
bia
result
toward
null
hypothesi
furthermor
crosssect
design
limit
conclus
confid
drawn
sinc
studi
design
detect
contribut
new
strain
acquisit
bacteria
virus
alri
onset
import
respiratori
disord
area
requir
condit
logist
regress
use
compar
microb
codetect
case
control
overal
preval
grey
cell
repres
signific
differ
p
codetect
case
scc
one
swab
miss
respiratori
bacteri
data
anoth
miss
viral
data
scc
tabl
denomin
bacteriabacteria
n
virusviru
n
viral
bacterialvir
n
investig
popul
high
rate
respiratori
bacteri
colon
pediatr
popul
high
risk
alri
high
preval
sever
respiratori
bacteri
viral
pathogen
identifi
np
collect
case
period
prior
alri
onset
control
whilst
retrospect
analysi
limit
sever
factor
hadv
pathogen
significantli
associ
alri
onset
requir
larg
set
longitudin
host
environment
microbi
data
includ
clinic
phenotyp
microbi
strain
model
account
multipl
parallel
effect
unpack
complex
interact
inform
use
develop
target
intervent
reduc
alri
burden
highrisk
popul
